VILAS PHARMACEUTICAL SERVICES ApS — Credit Rating and Financial Key Figures
CVR number: 35648275
Vermehrensvej 8, 4100 Ringsted
nielsen@vilaspharma.dk
tel: 26135309
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 977.55 | 711.78 | 1 287.24 | 1 052.32 | 1 104.26 |
Employee benefit expenses | - 592.59 | - 625.39 | - 759.94 | - 856.55 | - 958.69 |
Total depreciation | -50.75 | -46.38 | -46.38 | ||
EBIT | 334.21 | 40.00 | 480.92 | 195.77 | 145.57 |
Other financial income | 11.27 | 0.80 | 0.29 | 0.84 | 1.20 |
Other financial expenses | -4.13 | -7.89 | -18.76 | -8.58 | -16.23 |
Net income from associates (fin.) | 36.58 | 14.31 | -9.98 | 23.89 | 17.15 |
Pre-tax profit | 377.94 | 47.22 | 452.48 | 211.93 | 147.69 |
Income taxes | -84.86 | -16.91 | - 107.51 | -44.51 | -45.82 |
Net earnings | 293.07 | 30.31 | 344.97 | 167.42 | 101.87 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 185.53 | 139.15 | 92.77 | ||
Tangible assets total | 185.53 | 139.15 | 92.77 | ||
Participating interests | 268.78 | 283.09 | 273.11 | 297.00 | 314.16 |
Investments total | 268.78 | 283.09 | 273.11 | 297.00 | 314.16 |
Non-current loans receivable | 85.20 | 86.00 | 75.80 | 72.00 | 61.60 |
Long term receivables total | 85.20 | 86.00 | 75.80 | 72.00 | 61.60 |
Inventories total | |||||
Current trade debtors | 75.86 | 131.96 | 262.04 | 116.42 | 153.39 |
Current owed by particip. interest comp. | 11.75 | 11.75 | 11.61 | 11.61 | |
Prepayments and accrued income | 38.71 | 41.24 | |||
Current other receivables | 12.52 | 6.63 | 4.43 | 16.51 | 0.92 |
Short term receivables total | 88.38 | 150.35 | 278.22 | 183.25 | 207.16 |
Cash and bank deposits | 512.82 | 52.04 | 242.45 | 338.85 | 303.37 |
Cash and cash equivalents | 512.82 | 52.04 | 242.45 | 338.85 | 303.37 |
Balance sheet total (assets) | 1 140.71 | 710.62 | 962.35 | 891.11 | 886.29 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
Shares repurchased | 113.00 | 114.40 | 167.80 | 122.00 | 135.00 |
Other reserves | 83.78 | 98.09 | 88.11 | 112.00 | 129.16 |
Retained earnings | 75.96 | 240.32 | 112.80 | 311.87 | 327.14 |
Profit of the financial year | 293.07 | 30.31 | 344.97 | 167.42 | 101.87 |
Shareholders equity total | 615.81 | 533.11 | 763.68 | 763.30 | 743.17 |
Provisions | 3.79 | 12.42 | 6.76 | 12.75 | 9.07 |
Non-current liabilities total | |||||
Current trade creditors | 114.51 | 17.41 | 16.35 | 18.19 | 19.89 |
Current owed to participating | 67.50 | ||||
Short-term deferred tax liabilities | 98.55 | 54.98 | 83.40 | 27.04 | 48.43 |
Other non-interest bearing current liabilities | 240.55 | 92.70 | 92.16 | 69.83 | 65.73 |
Current liabilities total | 521.11 | 165.09 | 191.91 | 115.06 | 134.05 |
Balance sheet total (liabilities) | 1 140.71 | 710.62 | 962.35 | 891.11 | 886.29 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.